A comprehensive investigation of alternative pathways contributing to JNK mediated apoptosis in MM for better insight into the specific role of the JNK signaling pathway and its crosstalk with other crucial molecules in response to targeted treatment of multiple myeloma cells remains to be done. This evidence concerns the gene MAPK8 and Miyoshi myopathy.